1. Home
  2. NOV vs GKOS Comparison

NOV vs GKOS Comparison

Compare NOV & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOV
  • GKOS
  • Stock Information
  • Founded
  • NOV 1862
  • GKOS 1998
  • Country
  • NOV United States
  • GKOS United States
  • Employees
  • NOV N/A
  • GKOS N/A
  • Industry
  • NOV Metal Fabrications
  • GKOS Medical/Dental Instruments
  • Sector
  • NOV Industrials
  • GKOS Health Care
  • Exchange
  • NOV Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • NOV 4.9B
  • GKOS 5.8B
  • IPO Year
  • NOV 1996
  • GKOS 2015
  • Fundamental
  • Price
  • NOV $13.27
  • GKOS $94.64
  • Analyst Decision
  • NOV Buy
  • GKOS Strong Buy
  • Analyst Count
  • NOV 17
  • GKOS 12
  • Target Price
  • NOV $16.65
  • GKOS $131.17
  • AVG Volume (30 Days)
  • NOV 3.2M
  • GKOS 693.4K
  • Earning Date
  • NOV 10-23-2025
  • GKOS 11-03-2025
  • Dividend Yield
  • NOV 2.24%
  • GKOS N/A
  • EPS Growth
  • NOV N/A
  • GKOS N/A
  • EPS
  • NOV 1.21
  • GKOS N/A
  • Revenue
  • NOV $8,790,000,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • NOV N/A
  • GKOS $28.79
  • Revenue Next Year
  • NOV $0.35
  • GKOS $25.65
  • P/E Ratio
  • NOV $11.02
  • GKOS N/A
  • Revenue Growth
  • NOV N/A
  • GKOS 26.70
  • 52 Week Low
  • NOV $10.84
  • GKOS $77.10
  • 52 Week High
  • NOV $17.34
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • NOV 57.59
  • GKOS 52.87
  • Support Level
  • NOV $12.86
  • GKOS $89.83
  • Resistance Level
  • NOV $13.26
  • GKOS $97.00
  • Average True Range (ATR)
  • NOV 0.38
  • GKOS 2.65
  • MACD
  • NOV 0.09
  • GKOS 0.38
  • Stochastic Oscillator
  • NOV 85.66
  • GKOS 69.91

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: